Skip to main content
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 1, Number 1, 1 July 2000

Book Reviews

Preface
pp. i-i(1)
Author: Rolland, A.

Favourites:
ADD

Reviews

Rituximab The First Monoclonal Antibody Approved for the Treatment of Lymphoma
pp. 1-9(9)
Authors: Grillo-Lopez, A.J.; White, C.A.; Dallaire, B.K.; Varns, C.L.; Shen, C.D.; Wei, A.; Leonard, J.E.; McClure, A.; Weaver, R.; Cairelli, S.; Rosenberg, J.

Favourites:
ADD

Advances in Biotechnology for Tissue Engineering of Bone
pp. 47-55(9)
Authors: Ripamonti, U.; Tasker, J.R.

Favourites:
ADD
Favourites:
ADD

Health Care Discovery, Novo Nordisk A/S, DK-2880 Bagsværd, Denmark
pp. 63-71(9)
Authors: Boel, E.; Albrektsen, T.; Fleckner, J.; Selmer, J.

Favourites:
ADD

The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
pp. 73-82(10)
Authors: Ribatti, D.; Vacca, A.; Roncali, L.; Dammacco, F.

Favourites:
ADD
Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more